Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2178-2187

  Allie, S Rameeza ^a   Zhang, Weijun ^a   Tsai, Ching Yi ^a   Noelle, Randolph J ^a,b   Usherwood, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; EFFECTOR CELL; FLOW CYTOMETRY; LISTERIOSIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; POXVIRUS INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VACCINIA VIRUS INFECTION;

ANIMALS; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; GENE EXPRESSION; GRANZYMES; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TRETINOIN; VACCINIA; VACCINIA VIRUS;

EID: 84874272084     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201945     Document Type: Article

References (45)

1. White, R. J., Q. Nie, A. D. Lander, and T. F. Schilling. 2007. Complex regulation of cyp26a1 creates a robust retinoic acid gradient in the zebrafish embryo. PLoS Biol. 5: e304.
2. Kusmartsev, S., F. Cheng, B. Yu, Y. Nefedova, E. Sotomayor, R. Lush, and D. Gabrilovich. 2003. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63: 4441-4449.
3. Mohty, M., S. Morbelli, D. Isnardon, D. Sainty, C. Arnoulet, B. Gaugler, and D. Olive. 2003. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Br. J. Haematol. 122: 829-836.
4. Morikawa, K., and M. Nonaka. 2005. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 5: 1830-1838.
5. Worm, M., J. M. Krah, R. A. Manz, and B. M. Henz. 1998. Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood 92: 1713-1720.
6. Chen, Q., and A. C. Ross. 2007. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cell. Immunol. 249: 37-45.
7. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204: 1765-1774.
8. Lu, L., J. Ma, Z. Li, Q. Lan, M. Chen, Y. Liu, Z. Xia, J. Wang, Y. Han, W. Shi, et al. 2011. All-trans retinoic acid promotes TGF-b-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS ONE 6: e24590.
9. Kishi, M., H. Yasuda, Y. Abe, H. Sasaki, M. Shimizu, T. Arai, Y. Okumachi, H. Moriyama, K. Hara, K. Yokono, and M. Nagata. 2010. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes. Biochem. Biophys. Res. Commun. 394: 228-232.
10. Hall, J. A., J. L. Cannons, J. R. Grainger, L. M. Dos Santos, T. W. Hand, S. Naik, E. A. Wohlfert, D. B. Chou, G. Oldenhove, M. Robinson, et al. 2011. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity 34: 435-447.
11. Pino-Lagos, K., Y. Guo, C. Brown, M. P. Alexander, R. Elgueta, K. A. Bennett, V. De Vries, E. Nowak, R. Blomhoff, S. Sockanathan, et al. 2011. A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. J. Exp. Med. 208: 1767-1775.
12. Pohl, J., D. LaFace, and J. F. Sands. 1993. Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset. Mol. Biol. Rep. 17: 135-142.
13. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545.
14. Kaech, S. M., and E. J. Wherry. 2007. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27: 393-405.
15. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
16. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
17. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
18. Wilson, D. C., S. Matthews, and G. S. Yap. 2008. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection. J. Immunol. 180: 5935-5945.
19. Wiesel, M., J. Crouse, G. Bedenikovic, A. Sutherland, N. Joller, and A. Oxenius. 2012. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur. J. Immunol. 42: 320-329.
20. Cui, W., N. S. Joshi, A. Jiang, and S. M. Kaech. 2009. Effects of Signal 3 during CD8 T cell priming: bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine 27: 2177-2187.
21. Keppler, S. J., K. Theil, S. Vucikuja, and P. Aichele. 2009. Effector T-cell differentiation during viral and bacterial infections: role of direct IL-12 signals for cell fate decision of CD8(+) T cells. Eur. J. Immunol. 39: 1774-1783.
22. Rao, R. R., Q. Li, M. R. Gubbels Bupp, and P. A. Shrikant. 2012. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity 36: 374-387.
23. Takemoto, N., A. M. Intlekofer, J. T. Northrup, E. J. Wherry, and S. L. Reiner. 2006. Cutting edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J. Immunol. 177: 7515-7519.
24. Rutishauser, R. L., G. A. Martins, S. Kalachikov, A. Chandele, I. A. Parish, E. Meffre, J. Jacob, K. Calame, and S. M. Kaech. 2009. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31: 296-308.
25. Weninger, W., M. A. Crowley, N. Manjunath, and U. H. von Andrian. 2001. Migratory properties of naive, effector, and memory CD8(+) T cells. J. Exp. Med. 194: 953-966.
26. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
27. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
28. Rajaii, F., Z. T. Bitzer, Q. Xu, and S. Sockanathan. 2008. Expression of the dominant negative retinoid receptor, RAR403, alters telencephalic progenitor proliferation, survival, and cell fate specification. Dev. Biol. 316: 371-382.
29. Sudfeld, C. R., A. M. Navar, and N. A. Halsey. 2010. Effectiveness of measles vaccination and vitamin A treatment. Int. J. Epidemiol. 39(Suppl 1): i48-i55.
30. Benn, C. S., A. B. Fisker, B. M. Napirna, A. Roth, B. R. Diness, K. R. Lausch, H. Ravn, M. Yazdanbakhsh, A. Rodrigues, H. Whittle, and P. Aaby. 2010. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 340: c1101.
31. Dzhagalov, I., P. Chambon, and Y. W. He. 2007. Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J. Immunol. 178: 2113-2121.
32. Pino-Lagos, K., M. J. Benson, and R. J. Noelle. 2008. Retinoic acid in the immune system. Ann. N. Y. Acad. Sci. 1143: 170-187.
33. Curtsinger, J. M., C. S. Schmidt, A. Mondino, D. C. Lins, R. M. Kedl, M. K. Jenkins, and M. F. Mescher. 1999. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162: 3256-3262.
34. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
35. Turka, L. A., J. A. Ledbetter, K. Lee, C. H. June, and C. B. Thompson. 1990. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J. Immunol. 144: 1646-1653.
36. Harris, N. L., and F. Ronchese. 1999. The role of B7 costimulation in T-cell immunity. Immunol. Cell Biol. 77: 304-311.
37. Peng, S. L., A. J. Gerth, A. M. Ranger, and L. H. Glimcher. 2001. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14: 13-20.
38. Maruya, M., K. Suzuki, H. Fujimoto, M. Miyajima, O. Kanagawa, T.Wakayama, and S. Fagarasan. 2011. Vitamin A-dependent transcriptional activation of the nuclear factor of activated T cells c1 (NFATc1) is critical for the development and survival of B1 cells. Proc. Natl. Acad. Sci. USA 108: 722-727.
39. Motomura, K., M. Ohata, M. Satre, and H. Tsukamoto. 2001. Destabilization of TNF-αlpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. Am. J. Physiol. Endocrinol. Metab. 281: E420- E429.
40. Banerjee, A., S. M. Gordon, A. M. Intlekofer, M. A. Paley, E. C. Mooney, T. Lindsten, E. J. Wherry, and S. L. Reiner. 2010. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 185: 4988-4992.
41. Felli, M. P., A. Vacca, D. Meco, I. Screpanti, A. R. Farina, M. Maroder, S. Martinotti, E. Petrangeli, L. Frati, and A. Gulino. 1991. Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol. Cell. Biol. 11: 4771-4778.
42. Ertesvag, A., L. M. Austenaa, H. Carlsen, R. Blomhoff, and H. K. Blomhoff. 2009. Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice. Immunology 126: 514-522.
43. de Bree, G. J., E. M. van Leeuwen, T. A. Out, H. M. Jansen, R. E. Jonkers, and R. A. van Lier. 2005. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J. Exp. Med. 202: 1433-1442.
44. Tan, X., J. L. Sande, J. S. Pufnock, J. N. Blattman, and P. D. Greenberg. 2011. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J. Virol. 85: 8316-8327.
45. Guo, Y., K. Pino-Lagos, C. A. Ahonen, K. A. Bennett, J. Wang, J. L. Napoli, R. Blomhoff, S. Sockanathan, R. A. Chandraratna, E. Dmitrovsky, et al. 2012. A retinoic acid-rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells. Cancer Res. 72: 5230-5239.